Skip to main content
Equibles

Woodline Partners LP

Position in IMVT — Immunovant, Inc.

CIK 1784547 San Francisco, CA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$76,130,232
+$27,049,647 QoQ
Shares Held
1,975,869
0.0% QoQ
Ownership
0.957%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#17
of 226 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. IMVT ranks #11 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in IMVT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $76,130,232 1,975,869
2026-03-31 $49,080,585 1,975,869
2025-12-31 $50,226,589 1,975,869
2025-09-30 $24,159,447 1,498,725
2025-06-30 $23,979,600 1,498,725
2025-03-31 $25,598,581 1,497,869
2024-12-31 $15,920,323 642,726
2024-09-30 $40,340,994 1,414,977
2024-06-30 $48,138,156 1,823,415
2024-03-31 $41,663,874 1,289,504
2023-12-31 $31,608,706 750,266
2023-09-30 $37,011,146 964,083
2023-06-30 $12,047,676 635,091
2023-03-31 $2,134,051 137,592
2022-12-31 $14,501,022 816,959
2022-09-30 $9,844,738 1,764,290
2022-06-30 $359,190 92,100
2021-09-30 $2,099,495 241,599
2021-06-30 $39,643,577 3,750,575
2021-03-31 $14,381,736 896,617
2020-12-31 $13,944,899 301,903
2020-09-30 $4,967,772 141,170
2020-06-30 $5,622,609 230,908
2020-03-31 $5,061,473 325,183